Borderline Ductal Epithelial Lesions: Interobserver Reproducibility in 43 Cases with Original Diagnosis of Atypical Ductal Hyperplasia Bordering on Ductal Carcinoma In-Situ

被引：0
|
作者：
Tozbikian, G.
Brogi, E.
Catalano, J.
Patil, S.
Van Zee, K. J.
Kadivar, M.
Vallejo, C. E.
Wen, Y. H.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Tehran Med Sci, Rasool Akram Hosp, Tehran, Iran
来源：
LABORATORY INVESTIGATION | 2013年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
291
引用
收藏
页码：72A / 72A
页数：1
相关论文
共 50 条
  • [21] The Utilities of Estrogen Receptor, Cytokeratin 5/6, and Cytokeratin 903 to Differentiate Between Usual Ductal Hyperplasia, Flat Epithelial Atypia, Atypical Ductal Hyperplasia, Ductal Carcinoma In Situ, and Lobular Carcinoma In Situ
    Wei, Eric
    Dela Cruz, Nestor
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 : S30 - S30
  • [22] Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ
    Clauser, Paola
    Marino, Maria A.
    Baltzer, Pascal A. T.
    Bazzocchi, Massimo
    Zuiani, Chiara
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (03) : 335 - 346
  • [23] Atypical Ductal Hyperplasia (ADH)Versus Ductal Carcinoma In-Situ (DCIS) in a Papilloma: Comparison of Linear Dimension and Proportion Criteria
    Kalife, Elizabeth
    Singh, Kamaljeet
    Sung, C. James
    Quddus, M. Ruhul
    MODERN PATHOLOGY, 2016, 29 : 48A - 48A
  • [24] Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive ductal carcinoma of the breast
    Bofin, AM
    Fjosne, HE
    Hagmar, BM
    JOURNAL OF PATHOLOGY, 2002, 198 : 29A - 29A
  • [25] Atypical Ductal Hyperplasia (ADH) Versus Ductal Carcinoma In-Situ (DCIS) in a Papilloma: Comparison of Linear Dimension and Proportion Criteria
    Kalife, Elizabeth
    Singh, Kamaljeet
    Sung, C. James
    Quddus, M. Ruhul
    LABORATORY INVESTIGATION, 2016, 96 : 48A - 48A
  • [26] Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ
    Sneige, N
    Lagios, MD
    Schwarting, R
    Colburn, W
    Atkinson, E
    Weber, D
    Sahin, A
    Kemp, B
    Hoque, A
    Risin, S
    Sabichi, A
    Boone, C
    Dhingra, K
    Kelloff, G
    Lippman, S
    HUMAN PATHOLOGY, 1999, 30 (03) : 257 - 262
  • [27] Basal-Like Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ: Evidence for Precursors of Basal-Like Invasive Ductal Carcinoma
    Wang, Jing
    Middleton, Lavinia
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 204 - 205
  • [28] Basal-Like Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ: Evidence for Precursors of Basal-Like Invasive Ductal Carcinoma
    Wang, Jing
    Middleton, Lavinia
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 204 - 205
  • [29] Ductal carcinoma in situ of the breast: interobserver reproducibility of three classification schemes
    Schuh, F.
    Biazus, J. V.
    Resetkova, E.
    Benfica, C. Z.
    Edelweiss, M. I. A.
    EJC SUPPLEMENTS, 2010, 8 (03): : 170 - 170
  • [30] Borderline Atypical Ductal Hyperplasia/Low-grade Ductal Carcinoma In Situ on Breast Needle Core Biopsy Should Be Managed Conservatively
    VandenBussche, Christopher J.
    Khouri, Nagi
    Sbaity, Eman
    Tsangaris, Theodore N.
    Vang, Russell
    Tatsas, Armanda
    Cimino-Mathews, Ashley
    Argani, Pedram
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (06) : 913 - 923
12345